Secukinumab in a patient with sarcoidosis

dc.authoridŞenol Kobak / 0000-0001-8270-640Xen_US
dc.authoridAdil Can Güngen / 0000-0002-2676-723Xen_US
dc.authoridYıldıray Tutpınar / 0000-0001-9445-6604
dc.authorscopusidŞenol Kobak / 12782228700
dc.authorscopusidAdil Can Güngen / 56682130600
dc.authorscopusidBelma Doğan Güngen / 56841681700
dc.authorscopusidYıldıray Tutpınar / 25923172200
dc.authorscopusidMürüvet Güler / 57218710925
dc.authorwosidŞenol Kobak / AAO-2482-2020
dc.authorwosidAdil Can Güngen / CSH-3078-2022
dc.authorwosidBelma Doğan Güngen / CST-6053-2022
dc.authorwosidYıldıray Tutpınar / ECZ-3455-2022
dc.authorwosidMürüvet Güler / CRM-6695-2022
dc.contributor.authorKobak, Şenol
dc.contributor.authorGüngen, Adil Can
dc.contributor.authorDoğan Güngen, Belma
dc.contributor.authorTutpınar, Yıldıray
dc.contributor.authorGüler, Mehtap
dc.date.accessioned2020-09-10T13:27:31Z
dc.date.available2020-09-10T13:27:31Z
dc.date.issued2020
dc.departmentİstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractSarcoidosis is a systemic granulomatous disease, characterized by non-caseating granuloma formation. It usually involves the lungs, but may also affect the eyes, heart, skin, and musculoskeletal system. The pathogenesis is not well known, but it is generally accepted as Th1 disease. The role of Th17-induced cytokines in the development of sarcoid granuloma has been reported.en_US
dc.identifier.citationKobak, S., Gungen, A. C., Gungen, B. D., Tutpinar, Y., & Guler, M. (2020). Secukinumab in a patient with sarcoidosis. Scandinavian Journal of Rheumatology, 1-2.en_US
dc.identifier.doi10.1080/03009742.2020.1784460en_US
dc.identifier.issn0300-9742en_US
dc.identifier.pmid32870066en_US
dc.identifier.scopus2-s2.0-85090166204en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.urihttps://doi.org/10.1080/03009742.2020.1784460
dc.identifier.urihttps://hdl.handle.net/20.500.12713/1010
dc.identifier.wosWOS:000565011100001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorKobak, Şenol
dc.institutionauthorGüngen, Adil Can
dc.institutionauthorDoğan Güngen, Belma
dc.institutionauthorTutpınar, Yıldıray
dc.institutionauthorGüler, Mehtap
dc.language.isoenen_US
dc.publisherTaylor and Francis Ltden_US
dc.relation.ispartofScandinavian Journal of Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleSecukinumab in a patient with sarcoidosisen_US
dc.typeLetteren_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
makalee-sayfalar-2-3.pdf
Boyut:
687.87 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: